PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Bristol Medical School, Translational Health Sciences, University of Bristol, Bristol, U.K.\', \'School of Cellular and Molecular Medicine, University of Bristol, Bristol, U.K.\', \'Department of Pathology, University of Udine, Udine, Italy.\', \'School of Biochemistry, University of Bristol, Bristol, U.K.\', \'Medicines Discovery Institute, Cardiff University, Cardiff, U.K.\', \'Max Planck Bristol Centre for Minimal Biology, University of Bristol, Bristol, U.K.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1042/CS20210735
?:doi
?:hasPublicationType
?:journal
  • Clinical science (London, England : 1979)
is ?:pmid of
?:pmid
?:pmid
  • 34807265
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all